GlassScriptPhysician profile
Irina Borissova
NPI 1558301655
$397.73
in general payments reported to CMS, 2019-2025
10 companies · $51.13 in 2025
The $51.13 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $55.71 · 2023: $0.79 · 2024: $79.58 · 2025: $51.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.71 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $147.39 | 2019-2020 | |
| Boston Scientific Corporation | $79.58 | 2024 | Wavewriter Alpha Prime 16 |
| Exact Sciences Corporation | $51.13 | 2025 | The Cologuard Plus Collection Kit |
| Regeneron Healthcare Solutions, INC. | $29.53 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.53 | 2019-2020 | |
| Shire North American Group INC | $16.80 | 2019 | |
| Novo Nordisk INC | $14.84 | 2019 | |
| Pfizer INC. | $14.68 | 2019 | |
| Abbott Laboratories | $13.46 | 2019 | |
| Sumitomo Pharma America, INC. | $0.79 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Borissova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.